4,5-Dihydro-2-thiazolamine → HCID 89953865, compound
Reaction equation
[CH:1]1([O:7][CH2:8][C:9]2[N:13]3[CH:14]=[CH:15][C:16]([C:18]([NH:20][C:21]4[S:22][CH:23]=[CH:24][N:25]=4)=[O:19])=[CH:17][C:12]3=[N:11][C:10]=2[CH:26]([CH3:28])[CH3:27])[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.NC1SCCN=1>>[CH:1]1([O:7][CH2:8][C:9]2[N:13]3[CH:14]=[CH:15][C:16]([C:18]([NH:20][C:21]4[S:22][CH2:23][CH2:24][N:25]=4)=[O:19])=[CH:17][C:12]3=[N:11][C:10]=2[CH:26]([CH3:28])[CH3:27])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1Participants
3
Procedure
Compound 25 (8.9 mg, yield 14%) was obtained in the same manner as in step 4 of Example 21, using 3-cyclohexyloxymethyl-2-isopropyl[1,2-a]pyridine-7-carboxylic acid obtained in step 3 of Example 21, and 2-amino-4,5-dihydrothiazole.
Sources & evidence
- ORD record
- ord-318e3778392549bb8a8f4f4cd2d91d2b
- Source dataset
- uspto-grants-2015_04
- Patent number
- US09000186B2
Reaction notes
Loading…